QC
JAZZ icon

Quent Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Quent Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58K Sell
307
-40
-12% -$6.99K ﹤0.01% 696
2025
Q4 		$59K Buy
347
+11
+3% +$1.69K ﹤0.01% 706
2025
Q3 		$44.3K Buy
+336
New +$40.3K ﹤0.01% 636
2025
Q2 		– Sell
-339
Closed -$42.1K – 778
2025
Q1 		$42.1K Buy
339
+123
+57% +$16K ﹤0.01% 596
2024
Q4 		$26.6K Hold
216
– – ﹤0.01% 734
2024
Q3 		$24.1K Sell
216
-25
-10% -$2.74K ﹤0.01% 841
2024
Q2 		$25.7K Sell
241
-40
-14% -$4.4K ﹤0.01% 791
2024
Q1 		$33.8K Buy
281
+9
+3% +$1.1K ﹤0.01% 748
2023
Q4 		$33.5K Buy
272
+29
+12% +$3.62K ﹤0.01% 718
2023
Q3 		$31.5K Buy
243
+5
+2% +$666 ﹤0.01% 695
2023
Q2 		$29.5K Hold
238
– – ﹤0.01% 710
2023
Q1 		$34.8K Hold
238
– – 0.01% 675
2022
Q4 		$37.9K Sell
238
-44
-16% -$6.45K 0.01% 643
2022
Q3 		$38K Buy
282
+10
+4% +$1.52K 0.01% 617
2022
Q2 		$42K Sell
272
-30
-10% -$4.62K 0.01% 555
2022
Q1 		$47K Buy
302
+60
+25% +$8.71K 0.01% 616
2021
Q4 		$31K Buy
+242
New +$31.8K 0.01% 642

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Quent Capital's JAZZ Position: Q1 2026 in Review

Quent Capital reduced its Jazz Pharmaceuticals (JAZZ) stake by 12% in Q1 2026, selling an estimated $6.99K and leaving 307 shares worth $58K. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Quent Capital first reported a position in JAZZ in Q4 2021 and has held it in 17 quarters since. The position peaked at $59K in Q4 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Quent Capital held 307 shares of Jazz Pharmaceuticals worth $58K as of Q1 2026.
  • Quent Capital sold 40 Jazz Pharmaceuticals shares in Q1 2026, an estimated $6.99K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #696 holding.
  • Quent Capital first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's Jazz Pharmaceuticals position peaked at $59K in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.